Over the past 2 decades, natriuretic peptides have earned their rightful place in the
diagnosis and management of heart failure (HF). Clinical guidelines have emphasized the …

Natriuretic peptides offer the possibility to diagnose acute heart failure with high accuracy
and particularly high negative predictive value with a simple biochemistry measurement …

Tremendous advances have been made in understanding the pathophysiology and
treatment of congestive heart failure (CHF). However, diagnosis still remains difficult, even …

Background Emerging data indicates that natriuretic peptide biomarker-based screening
and early intervention could prevent left ventricular dysfunction or new-onset heart failure …

Congestive heart failure (CHF) is a progressive disease whose outcome largely depends on
early, accurate and prompt diagnosis, accompanied by evidence-based treatment. The …

Over the past decade, an evidence base has accumulated to support natriuretic peptide
(NP) testing for diagnosis, risk assessment, and therapeutic monitoring and guidance of …

Heart failure is a clinical syndrome that manifests from various cardiac and noncardiac
abnormalities. Accordingly, rapid and readily accessible methods for diagnosis and risk …

Many studies have described the role of B-type natriuretic peptide or its amino-terminal
byproduct (NT-pro-B-type natriuretic peptide) in clinical practice, including several published …

Assessment of natriuretic peptide (NP) levels has a well‐established role in the diagnosis
and prognosis of acute heart failure (AHF) patients. Current guidelines recommend …

The natriuretic peptides are important tools to establish diagnosis and prognosis in heart
failure (HF). With application of therapies for HF, changes in both B-type natriuretic peptide …